Literature DB >> 17599468

GABA (A) receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6/IL-12 production.

Maria Guadalupe Reyes-García1, Francisca Hernández-Hernández, Beatriz Hernández-Téllez, Fernando García-Tamayo.   

Abstract

The expression and functionality of the gamma aminobutyric acid A receptor (GABA(A)R) in mice macrophages was explored. Reverse Transcriptase-Polymerase Chain Reaction showed that macrophages express the GABA(A)R RNA for the alpha1, alpha2, beta3 and delta subunits, but not for the alpha5, beta1, beta2 and gamma3 subunits. The expression of alpha1 subunit was also revealed by confocal microscopy. LPS-stimulated macrophages significantly reduced their in vitro production of IL-6 and IL-12 after GABA adding to the culture medium. These results showed that BALB/c mice peritoneal macrophages express a functional subset of GABA(A)R subunits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599468     DOI: 10.1016/j.jneuroim.2007.05.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  41 in total

1.  Gamma-aminobutyric acid inhibits synergistic interleukin-6 release but not transcriptional activation in astrocytoma cells.

Authors:  Joseph D Roach; Grant T Aguinaldo; Kaumudi Jonnalagadda; Francis M Hughes; Bryan L Spangelo
Journal:  Neuroimmunomodulation       Date:  2008-08-05       Impact factor: 2.492

2.  Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis.

Authors:  Jide Tian; Jing Yong; Hoa Dang; Daniel L Kaufman
Journal:  Autoimmunity       Date:  2011-05-23       Impact factor: 2.815

3.  Therapeutic Action of Honokiol on Postoperative Ileus via Downregulation of iNOS Gene Expression.

Authors:  Taiki Mihara; Shoma Mikawa; Noriyuki Kaji; Mari Endo; Tetsuro Oikawa; Jan Tong-Rong; Hiroshi Ozaki; Masatoshi Hori
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

4.  GABAA receptor α4-subunit knockout enhances lung inflammation and airway reactivity in a murine asthma model.

Authors:  Gene T Yocum; Damian L Turner; Jennifer Danielsson; Matthew B Barajas; Yi Zhang; Dingbang Xu; Neil L Harrison; Gregg E Homanics; Donna L Farber; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-04       Impact factor: 5.464

5.  Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress.

Authors:  Enrique Sánchez-Lemus; Masaru Honda; Juan M Saavedra
Journal:  Behav Brain Res       Date:  2012-04-04       Impact factor: 3.332

Review 6.  Mechanisms of the Immunological Effects of Volatile Anesthetics: A Review.

Authors:  Koichi Yuki; Roderic G Eckenhoff
Journal:  Anesth Analg       Date:  2016-08       Impact factor: 5.108

7.  Verification of γ-Amino-Butyric Acid (GABA) Signaling System Components in Periodontal Ligament Cells In Vivo and In Vitro.

Authors:  Anna Konermann; Alpdogan Kantarci; Steven Wilbert; Thomas Van Dyke; Andreas Jäger
Journal:  Cell Mol Neurobiol       Date:  2016-02-10       Impact factor: 5.046

8.  G-Aminobutyric acid promotes methionine-choline deficient diet-induced nonalcoholic steatohepatitis.

Authors:  Seok Roh Yoon; Cho Ara; Zhou Zixiong; Jeong Hyuneui; Park Jeong-Eun; Cha Youn-Soo; Oh Suk-Heung; Lim Chae-Woong; Kim Bumseok
Journal:  J Biomed Res       Date:  2016-10-17

9.  Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.

Authors:  Naresha Saligrama; Laure K Case; Roxana del Rio; Rajkumar Noubade; Cory Teuscher
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

10.  Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments.

Authors:  Gloria S Forkuo; Margaret L Guthrie; Nina Y Yuan; Amanda N Nieman; Revathi Kodali; Rajwana Jahan; Michael R Stephen; Gene T Yocum; Marco Treven; Michael M Poe; Guanguan Li; Olivia B Yu; Benjamin D Hartzler; Nicolas M Zahn; Margot Ernst; Charles W Emala; Douglas C Stafford; James M Cook; Leggy A Arnold
Journal:  Mol Pharm       Date:  2016-05-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.